Meaning of Recovery After Lung Cancer Surgery

July 22, 2022 updated by: Hojin Lee, MD, Seoul National University Hospital

Meaning of Recovery to Patients Undergoing Lung Cancer Surgery: A Prospective Observational Study

The purpose of this study is to find out the meaning of recovery after lung cancer surgery from a patient's point of view. The results of this study would help improve postoperative recovery in lung cancer patients.

Study Overview

Status

Recruiting

Detailed Description

In patients undergoing video-assisted thoracic surgery (VATS) lung resection for lung cancer, the survey on the 'meaning of recovery after surgery' are conducted before surgery, 2 days after surgery, and 30 days after surgery. The questionnaire includes importance score of each question regarding the meaning of recovery after lung cancer surgery.

After 2 days of surgery and 30 days after surgery, the questionnaire about the recovery score and the part where the patients felt difficulties are conducted to investigate what recovery means from a patient's point of view. Length of hospital and ICU stay and postoperative complications are also evaluated.

Study Type

Observational

Enrollment (Anticipated)

111

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients aged 19 to 80 years undergoing video-assisted thoracic surgery (VATS) lung resection for lung cancer

Description

Inclusion Criteria:

  • Patients aged 19 to 80 years undergoing video-assisted thoracic surgery (VATS) lung resection for lung cancer
  • Patients who can provide written consent to participate in clinical trials, understand the procedures of this clinical trial, and properly fill out patient-reported questionnaires or respond appropriately to interviews

Exclusion Criteria:

  • Patients who did not consent to the trial
  • Patients who have difficulty filling out questionnaires or answering interviews about the meaning of recovery
  • Patients judged to be inappropriate for this clinical trial based on the opinion of the investigator or investigator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Importance score of each question regarding the meaning of recovery after lung cancer surgery before surgery
Time Frame: 1 day before surgery
Importance score of each question regarding the meaning of recovery after lung cancer surgery. The survey includes questions about returning to daily life, resolution of symptoms, overcoming mental strains, regaining independence, and enjoying life. Each question is evaluated on a scale of 1-5, higher number means more importance to the patient.
1 day before surgery
Importance score of each question regarding the meaning of recovery after lung cancer surgery at postoperative day 2
Time Frame: postoperative day 2
Importance score of each question regarding the meaning of recovery after lung cancer surgery. The survey includes questions about returning to daily life, resolution of symptoms, overcoming mental strains, regaining independence, and enjoying life. Each question is evaluated on a scale of 1-5, higher number means more importance to the patient.
postoperative day 2
Importance score of each question regarding the meaning of recovery after lung cancer surgery at postoperative day 30
Time Frame: postoperative day 30 (between day 25 and 35)
Importance score of each question regarding the meaning of recovery after lung cancer surgery. The survey includes questions about returning to daily life, resolution of symptoms, overcoming mental strains, regaining independence, and enjoying life. Each question is evaluated on a scale of 1-5, higher number means more importance to the patient.
postoperative day 30 (between day 25 and 35)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recovery score (0~100 scale)
Time Frame: postoperative day 2, and postoperative day 30 (between day 25 and 35)
Patient self-assessed recovery score (0-100 scale, higher number means better recovery)
postoperative day 2, and postoperative day 30 (between day 25 and 35)
Recovery score evaluated with 15-item Quality of Recovery (QoR-15K) scale
Time Frame: postoperative day 2
Recovery score evaluated with QoR-15K scale (0-150 scale, higher number means better recovery)
postoperative day 2
Length of hospital stay (day)
Time Frame: Hospital discharge, an average of 3 days
Days from the end of surgery to discharge
Hospital discharge, an average of 3 days
Length of ICU stay (day)
Time Frame: ICU discharge, an average of 1 day
Days from the end of surgery to ICU discharge
ICU discharge, an average of 1 day
Postoperative complication
Time Frame: Postoperative day 30
Postoperative complication related to surgery until postoperative day 30
Postoperative day 30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 18, 2022

Primary Completion (Anticipated)

July 10, 2024

Study Completion (Anticipated)

August 10, 2024

Study Registration Dates

First Submitted

July 3, 2022

First Submitted That Met QC Criteria

July 11, 2022

First Posted (Actual)

July 12, 2022

Study Record Updates

Last Update Posted (Actual)

July 27, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

3
Subscribe